Navigation Links
The Humana Foundation and Libraries for the Future Launch Health Literacy Pilot in Atlanta
Date:9/12/2007

Wellness Information Zone Project Helps with Access to Reliable Health Care

Information

ATLANTA, Sept. 12 /PRNewswire-FirstCall/ -- To address the growing problem of low health literacy levels and to help consumers access usable health information, The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), and Libraries for the Future, a national nonprofit organization dedicated to increasing innovation and investment in our nation's libraries, today launched the Wellness Information Zone, a new consumer health information project in Atlanta.

The program aims to bring together expertise and resources from the two partner organizations to help the 90 million Americans who have difficulty obtaining, understanding and acting on basic health information and services.

The Wellness Information Zone centers will be piloted in Atlanta through a partnership with the Fulton and DeKalb County public library systems. The new high-tech, high-touch Zones will enable Atlantans to access trustworthy information through an innovative, easy-to-use Web site and the option of seeking help from specially trained librarians or volunteer guides.

The information can be obtained through the program's Web site -- http://www.wellzone.org -- or through the Wellness Information Zones located at eight libraries throughout the metropolitan Atlanta area and the nonprofit organization, Genesis A New Life.

"Research shows that low health literacy is the strongest predictor of health problems, more than age, income, employment status or race," said Virginia K. Judd, executive director of The Humana Foundation. "By addressing thi
'/>"/>

SOURCE Humana Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...vidence of a statistically significant survival be... estrogen receptor (ER)-positive tumors had high l...8 (ER-alpha S118-P), according to a brief communic... of the National Cancer Institute . , Approximat...xifen. Preclinical studies have shown that ER-alph...
(Date:11/25/2009)... fight rheumatoid arthritis, could help newly diag...AY, Nov. 25 (HealthDay News) -- A drug commonly us...arthritis now also shows some promise in helping p... The drug, rituximab (Rituxan), helped patients ke...h the disease had destroyed some of their pancreat...
(Date:11/25/2009)... sees few signs of trouble with the H1N1 vaccine,... -- The ongoing H1N1 swine flu pandemic may be dri...younger patients, a U.S. health official said Wedn...pneumococcal infections around the country," Dr. A...Immunization and Respiratory Diseases at the U.S. ...
(Date:11/25/2009)...ncer vaccine carried into the body on a carefully ...to successfully eliminate tumors in mammals, scien...nslational Medicine . , The new approach, pionee...niversity, uses plastic disks impregnated with tum...to reprogram the mammalian immune system to attack...
(Date:11/25/2009)...n flesh that mimicked parts of speech colored perc...(HealthDay News) -- People can "hear" not only wit...ch shows. , In fact, sensations on the skin des...lped people decipher sounds better, the Canadian s...show whether we could use tactile information in t...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3
...r Martin Watterson and team from Northwestern Univ...ew compound called MW01-5-188WH which has been fou... Cytokines which leads to activation of glia, whic...lzheimer’s disease is characterized by loss in mem...
...ria parasites can develop in the lymph nodes also,...ard. This reportedly has implications for the mamm...se is caused when a mosquito infected with Plasmod...s and infect red blood cells, beginning the onset ...
...published in the Journal of Infectious Diseases ha...f Staphylococcus aureus in nasal samples, // among...ive factor in a majority of the hospital acquired ...n the US. About 1% of the nasal samples test...
...r Rosemary Crompton conducted a survey in 5 Europe...ween work life and domestic life // to find out w... would like to have a traditional life style, the ... Researchers found that women who worked hard...
...n who underwent the world’s first face transplant ...hospital. Doctors say that she is increasing the r... Isabelle Dinoire, 38, hailing from France was...e donor of the face was a 46-year old teacher who ...
...k antibiotic drug which is used for treating lung ... failure, according to a report. //Medical practit...aid that they found three cases of liver failure i...f each other last year, said report co-author John...
Other Medicine News:Health News:Malaria Can Develop In Lymph Nodes Also 2Health News:90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose 2
(Date:11/25/2009)...PARK,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTe...efoamthatstopsseverebleeding,wonfirstprizeand$10,0...lSecurityChallenge2009,companyofficialsannouncetod...theworld,Remedium,steampitchedtheirinventionattheG...usiness. ,, Remedium( www.remediumtechnologies....
(Date:11/25/2009)...China,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSkyO...)(Nasdaq: CSKI ),a,leadingfullyintegratedpharmaceu...rdrugsinthePeople,sRepublicofChina("PRC"),today,an...nalInstitutefor,theControlofPharmaceuticalandBiolo...oducts:itsDiagnosticKitforHumanProstateSpecific,An...
(Date:11/25/2009)...TY,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc...ingpoint-of-carebloodanalysissystems,announcedtoda...r,willpresentatthe21stAnnualPiperJaffrayHealthCare...heconferencewillbeheldattheNewYorkPalaceHotelinNew...,manufacturesandmarketsportablebloodanalysissystem...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Treating Workers Mental Woes May Boost Productivity 56746 1Treating Workers Mental Woes May Boost Productivity 56746 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 1Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 1QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 2QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 3QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 4
... GlaxoSmithKline (NYSE: GSK ),announced positive...d placebo-,controlled ITP Study with Eltrombopag),... adults with chronic immune (idiopathic) thrombocy... prior ITP therapies. Patients,receiving PROMACTA ... to,maintain platelet counts between 50,000 to 400...
...Bayer HealthCare Pharmaceuticals Inc. announced to...ine(R) (sargramostim) will be presented at the 50t...logy (ASH) from December 6-9, 2008 in San Francisc...m leading oncology and hematology research centers... presentations reporting important findings in leu...
Other Medicine Technology:GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 2GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 3GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 4GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 5GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 6GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 7GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP 8Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 2Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 3Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 4Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 5Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology 6
Liquichek Urinalysis Control
qUAntify Plus Control
Lyphochek Fertility Control
Liquichek Spinal Fluid Control
Medicine Products: